Alden Global Capital LLC - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 159 filers reported holding NOVAVAX INC in Q2 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alden Global Capital LLC ownership history of NOVAVAX INC
ValueSharesWeighting
Q4 2016$807,000
-81.5%
640,500
+6.8%
0.28%
-92.7%
Q2 2016$4,362,000
-15.5%
600,000
-40.0%
3.76%
+80.3%
Q1 2016$5,160,000
+57.0%
1,000,000
+239.0%
2.08%
-43.2%
Q2 2015$3,286,000295,0003.67%
Other shareholders
NOVAVAX INC shareholders Q2 2015
NameSharesValueWeighting ↓
BB BIOTECH AG 8,330,000$10,496,0000.39%
Alden Global Capital LLC 640,500$807,0000.28%
Quantitative Investment Management, LLC 3,784,100$4,767,0000.12%
Eventide Asset Management 1,449,700$1,827,0000.12%
Bellevue Group AG 325,000$410,0000.08%
Virtus ETF Advisers LLC 196,162$247,0000.07%
Rock Springs Capital Management LP 820,000$1,033,0000.07%
Quantbot Technologies LP 462,250$582,0000.06%
Traynor Capital Management, Inc. 43,361$55,0000.04%
Tekla Capital Management LLC 571,000$719,0000.03%
View complete list of NOVAVAX INC shareholders